KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Staar Surgical (STAA) Net Cash Flow (2016 - 2025)

Historic Net Cash Flow for Staar Surgical (STAA) over the last 16 years, with Q3 2025 value amounting to $8.9 million.

  • Staar Surgical's Net Cash Flow rose 12996.65% to $8.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.0 million, marking a year-over-year decrease of 6668.8%. This contributed to the annual value of -$37.8 million for FY2024, which is 13919.63% down from last year.
  • Latest data reveals that Staar Surgical reported Net Cash Flow of $8.9 million as of Q3 2025, which was up 12996.65% from -$6.7 million recorded in Q2 2025.
  • In the past 5 years, Staar Surgical's Net Cash Flow registered a high of $54.7 million during Q4 2023, and its lowest value of -$72.7 million during Q3 2022.
  • In the last 5 years, Staar Surgical's Net Cash Flow had a median value of $7.1 million in 2023 and averaged $2.5 million.
  • Its Net Cash Flow has fluctuated over the past 5 years, first crashed by 131193.99% in 2022, then surged by 110537.67% in 2024.
  • Staar Surgical's Net Cash Flow (Quarter) stood at $3.6 million in 2021, then plummeted by 1311.94% to -$43.5 million in 2022, then skyrocketed by 225.7% to $54.7 million in 2023, then crashed by 134.64% to -$19.0 million in 2024, then soared by 147.11% to $8.9 million in 2025.
  • Its Net Cash Flow was $8.9 million in Q3 2025, compared to -$6.7 million in Q2 2025 and $28.7 million in Q1 2025.